The Potential Effects of Inofolic Plus on Abnormal Ovarian Reserve Parameters in Subfertile Women
Launched by PALM BEACH CENTER FOR REPRODUCTIVE MEDICINE · Feb 3, 2011
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Inofolic Plus® contains several nutritional elements including myo-inositol, melatonin, and folic acid. Myo-inositol was found to be helpful in improving egg quality and/or quantity in women with an ovarian abnormality called polycystic ovarian syndrome as well as in women without the disorder undergoing assisted reproduction.
Myo-inositol and folic acid are compounds that belong to the family of B-vitamins. Inositol is normally found in several types of foods. Folic acid has been found to significantly decrease the incidence of certain types of birth defects in women taking sufficient amo...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female between 18 - 42 years of age
- • Diagnosed with "Diminished Ovarian Reserve" (DOR)
- Exclusion Criteria:
- • Ongoing history of illicit drug or tobacco use
- • Ovarian surgery within 90 days of signing the consent form
Trial Officials
Scott Roseff, MD
Principal Investigator
Palm Beach Center for Reproductive Medicine
About Palm Beach Center For Reproductive Medicine
The Palm Beach Center for Reproductive Medicine is a leading clinical research facility dedicated to advancing reproductive health through innovative treatments and comprehensive patient care. Specializing in fertility preservation, in vitro fertilization (IVF), and other assisted reproductive technologies, the center combines state-of-the-art medical practices with a compassionate approach to support individuals and couples on their journey to parenthood. With a commitment to clinical excellence and groundbreaking research, the Palm Beach Center for Reproductive Medicine strives to enhance outcomes and provide hope for those facing challenges in reproduction.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wellington, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials